LOW-HEMOLYSIS VITAMIN E INJECTION SOLUTION

PURPOSE:The title injection solution that is obtained by adding a specific saccharide to an aqueous injection solution of vitamin E which has been solubilized with a nonionic surface active agent, thus showing extremely lower hemolysis than conventional solutions and causing no clouding with high st...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: IMAMORI KATSUMI, MURATA TEIJI, IWASA AKIRA, NISHIWAKI SHIGERU
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator IMAMORI KATSUMI
MURATA TEIJI
IWASA AKIRA
NISHIWAKI SHIGERU
description PURPOSE:The title injection solution that is obtained by adding a specific saccharide to an aqueous injection solution of vitamin E which has been solubilized with a nonionic surface active agent, thus showing extremely lower hemolysis than conventional solutions and causing no clouding with high stability for a long period of time. CONSTITUTION:A vitamin E which has been solubilized with a nonionic surface active agent such as hardened castor oil polyoxyethylene derivative is dissolved in water to prepare a aqueous injection solution of vitamin E and it is bombined with 1.0-20wt% of mono-, di-saccharide, sugar alcohol to give the objective vitamin E injection solution of reduced hemolysis. It was found that the addition of a saccharide can lower than hemolysis caused by the surface active agent. The hemolysis in this injection solution is almost same a in case where it is give orally, therefore it can be safely used in intramuscular and intravenous injections.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JPS6117512A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JPS6117512A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JPS6117512A3</originalsourceid><addsrcrecordid>eNrjZNDy8Q_X9XD19feJDPYMVgjzDHH09fRTcFXw9PNydQ7x9PdTCPb3CQUxeBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvFdAsJmhobmpoZGjMRFKADB7JM4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>LOW-HEMOLYSIS VITAMIN E INJECTION SOLUTION</title><source>esp@cenet</source><creator>IMAMORI KATSUMI ; MURATA TEIJI ; IWASA AKIRA ; NISHIWAKI SHIGERU</creator><creatorcontrib>IMAMORI KATSUMI ; MURATA TEIJI ; IWASA AKIRA ; NISHIWAKI SHIGERU</creatorcontrib><description>PURPOSE:The title injection solution that is obtained by adding a specific saccharide to an aqueous injection solution of vitamin E which has been solubilized with a nonionic surface active agent, thus showing extremely lower hemolysis than conventional solutions and causing no clouding with high stability for a long period of time. CONSTITUTION:A vitamin E which has been solubilized with a nonionic surface active agent such as hardened castor oil polyoxyethylene derivative is dissolved in water to prepare a aqueous injection solution of vitamin E and it is bombined with 1.0-20wt% of mono-, di-saccharide, sugar alcohol to give the objective vitamin E injection solution of reduced hemolysis. It was found that the addition of a saccharide can lower than hemolysis caused by the surface active agent. The hemolysis in this injection solution is almost same a in case where it is give orally, therefore it can be safely used in intramuscular and intravenous injections.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>1986</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19860125&amp;DB=EPODOC&amp;CC=JP&amp;NR=S6117512A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19860125&amp;DB=EPODOC&amp;CC=JP&amp;NR=S6117512A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>IMAMORI KATSUMI</creatorcontrib><creatorcontrib>MURATA TEIJI</creatorcontrib><creatorcontrib>IWASA AKIRA</creatorcontrib><creatorcontrib>NISHIWAKI SHIGERU</creatorcontrib><title>LOW-HEMOLYSIS VITAMIN E INJECTION SOLUTION</title><description>PURPOSE:The title injection solution that is obtained by adding a specific saccharide to an aqueous injection solution of vitamin E which has been solubilized with a nonionic surface active agent, thus showing extremely lower hemolysis than conventional solutions and causing no clouding with high stability for a long period of time. CONSTITUTION:A vitamin E which has been solubilized with a nonionic surface active agent such as hardened castor oil polyoxyethylene derivative is dissolved in water to prepare a aqueous injection solution of vitamin E and it is bombined with 1.0-20wt% of mono-, di-saccharide, sugar alcohol to give the objective vitamin E injection solution of reduced hemolysis. It was found that the addition of a saccharide can lower than hemolysis caused by the surface active agent. The hemolysis in this injection solution is almost same a in case where it is give orally, therefore it can be safely used in intramuscular and intravenous injections.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1986</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDy8Q_X9XD19feJDPYMVgjzDHH09fRTcFXw9PNydQ7x9PdTCPb3CQUxeBhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvFdAsJmhobmpoZGjMRFKADB7JM4</recordid><startdate>19860125</startdate><enddate>19860125</enddate><creator>IMAMORI KATSUMI</creator><creator>MURATA TEIJI</creator><creator>IWASA AKIRA</creator><creator>NISHIWAKI SHIGERU</creator><scope>EVB</scope></search><sort><creationdate>19860125</creationdate><title>LOW-HEMOLYSIS VITAMIN E INJECTION SOLUTION</title><author>IMAMORI KATSUMI ; MURATA TEIJI ; IWASA AKIRA ; NISHIWAKI SHIGERU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JPS6117512A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1986</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>IMAMORI KATSUMI</creatorcontrib><creatorcontrib>MURATA TEIJI</creatorcontrib><creatorcontrib>IWASA AKIRA</creatorcontrib><creatorcontrib>NISHIWAKI SHIGERU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>IMAMORI KATSUMI</au><au>MURATA TEIJI</au><au>IWASA AKIRA</au><au>NISHIWAKI SHIGERU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>LOW-HEMOLYSIS VITAMIN E INJECTION SOLUTION</title><date>1986-01-25</date><risdate>1986</risdate><abstract>PURPOSE:The title injection solution that is obtained by adding a specific saccharide to an aqueous injection solution of vitamin E which has been solubilized with a nonionic surface active agent, thus showing extremely lower hemolysis than conventional solutions and causing no clouding with high stability for a long period of time. CONSTITUTION:A vitamin E which has been solubilized with a nonionic surface active agent such as hardened castor oil polyoxyethylene derivative is dissolved in water to prepare a aqueous injection solution of vitamin E and it is bombined with 1.0-20wt% of mono-, di-saccharide, sugar alcohol to give the objective vitamin E injection solution of reduced hemolysis. It was found that the addition of a saccharide can lower than hemolysis caused by the surface active agent. The hemolysis in this injection solution is almost same a in case where it is give orally, therefore it can be safely used in intramuscular and intravenous injections.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_JPS6117512A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title LOW-HEMOLYSIS VITAMIN E INJECTION SOLUTION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T17%3A52%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=IMAMORI%20KATSUMI&rft.date=1986-01-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJPS6117512A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true